The development and manufacturing of compounds by companies to fight diseases and combat ailments can often cost hundreds of millions of dollars. Let’s imagine a scenario. A company discovers a novel compound that can now cure a once incurable disease or virus that impacts millions of people (e.g. Cancer, AIDS, Influenza), does that company now have the right to charge whatever it costs to earn back the money it invested in time and capital? Take a definitive side, pro or con and argue why or why they shouldn’t be allowed to charge for a cure. Refer to:
https://www.brookings.edu/essay/addressing-the-trade-off-between-lower-drug-prices-and-incentives-for-pharmaceutical-innovation/
https://www.brookings.edu/essay/government-regulated-or-negotiated-drug-prices-key-design-considerations/
https://www.healthaffairs.org/do/10.1377/forefront.20171113.880918/full/
to support your post.
